How safe is aggressive statin therapy?

Progress in cardiovascular nursing

Volumn 21, Issue 3, 2006, Pages 140-145

  Guthrie, Robert M ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; FLUOROBENZENE; HEPTANOIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PYRIMIDINE DERIVATIVE; PYRROLE DERIVATIVE; ROSUVASTATIN; SIMVASTATIN; SULFONAMIDE;

CHEMICALLY INDUCED DISORDER; DRUG INTERACTION; DRUG TOXICITY; HUMAN; HYPERCHOLESTEROLEMIA; MUSCLE DISEASE; REVIEW; TOXIC HEPATITIS;

DRUG INTERACTIONS; DRUG TOXICITY; FLUOROBENZENES; HEPATITIS, TOXIC; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MUSCULAR DISEASES; PYRIMIDINES; PYRROLES; SIMVASTATIN; SULFONAMIDES;

EID: 33750125630     PISSN: 08897204     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0889-7204.2006.05616.x     Document Type: Review

References (38)